Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model.

被引：0
|
作者：
Ciccone, David [1 ]
Lazari, Vad [2 ]
Linney, Ian [2 ]
Briggs, Michael [2 ]
Carreiro, Samantha [1 ]
Loh, Christine [1 ]
Tummino, Peter [1 ]
McElwee, Joshua [1 ]
Collis, Alan [1 ]
Kaila, Neelu [1 ]
机构：
[1] Nimbus Therapeut, Cambridge, MA USA
[2] Charles River Labs, Chesterford Res Pk, Saffron Walden, Essex, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1649
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8+ T cell immunity
    Huang, Xiao-Li
    Fan, Zheng
    Borowski, Luann
    Rinaldo, Charles R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (06) : 1530 - 1540
  • [32] PD-1 BLOCKADE ADMINISTERED BEFORE OR AT THE TIME OF T CELL ACTIVATION ENHANCES ANTI-TUMOR IMMUNITY
    Moseman, Jena
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A492 - A492
  • [33] Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
    Betts, Brian C.
    Locke, Frederick L.
    Sagatys, Elizabeth M.
    Pidala, Joseph
    Walton, Kelly
    Menges, Meghan
    Reff, Jordan
    Saha, Asim
    Djeu, Julie Y.
    Kiluk, John V.
    Lee, Marie C.
    Kim, Jongphil
    Kang, Chang Won
    Tang, Chih-Hang Anthony
    Frieling, Jeremy
    Lynch, Conor C.
    List, Alan
    Rodriguez, Paulo C.
    Blazar, Bruce R.
    Conejo-Garcia, Jose R.
    Del Valle, Juan R.
    Hu, Chih-Chi Andrew
    Anasetti, Claudio
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [34] Effect of MMP9 inhibition on effector T-cell responses in a PD1-axis refractory model.
    Smith, Victoria
    Juric, Vladi
    Mikels-Vigdal, Amanda
    O'Sullivan, Chris
    Kovalenko, Maria
    Degenhardt, Jeremiah
    Yue, Peng
    Sriram, Venkataraman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [35] FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice
    Luo, Yunping
    Markowitz, Dorothy
    Xiang, Rong
    Zhou, He
    Reisfeld, Ralph A.
    VACCINE, 2007, 25 (08) : 1409 - 1415
  • [36] TUMOR METASTASES AND CELL-MEDIATED-IMMUNITY IN A SYNGENEIC MURINE TUMOR MODEL SYSTEM - INCREASE IN METASTASIZING PROPERTY ASSOCIATED WITH DECREASED IMMUNOGENICITY AND ABILITY TO INDUCE CYTOTOXIC T-CELLS INVITRO
    SCHIRRMACHER, V
    SHANTZ, G
    ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1978, 154 (04): : 360 - 360
  • [37] KY-B602, a humanized anti-human OX40 antibody, enhances CD4+T cell activation and inhibits tumor growth in a syngeneic model
    Hao, Feng
    He, Feng
    Ning, Mingxuan
    Bai, Zhaoshuai
    Ning, Jinying
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation
    Joshi, Sunil K.
    Lang, Gillian A.
    Devera, T. Scott
    Johnson, Amy M.
    Kovats, Susan
    Lang, Mark L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (05) : 783 - 790
  • [39] INHIBITION OF HUMAN T-CELL TUMOR-GROWTH BY T101-RICIN A-CHAIN IN AN ATHYMIC MOUSE MODEL
    LEONARD, JE
    JOHNSON, DE
    SHAWLER, DL
    DILLMAN, RO
    CANCER RESEARCH, 1988, 48 (17) : 4862 - 4867
  • [40] Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
    Yu, Ping
    Steel, Jason C.
    Zhang, Meili
    Morris, John C.
    Waitz, Rebecca
    Fasso, Marcella
    Allison, James P.
    Waldmann, Thomas A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (16) : 6187 - 6192
12345